{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:32:22Z","timestamp":1762507942910,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.annder.2019.08.018","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T18:48:43Z","timestamp":1574362123000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["M\u00e9lanome au stade ganglionnaire\u00a0: analyse du ganglion sentinelle, curage ganglionnaire, perspective des traitements adjuvants. Enqu\u00eate nationale fran\u00e7aise sur les pratiques actuelles et envisag\u00e9es"],"prefix":"10.1016","volume":"147","author":[{"given":"C.","family":"Orion","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dinulescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dalac-Rat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Giacchero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Jouary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lebb\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-T.","family":"Leccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Maubec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mortier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2019.08.018_bib0120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.annder.2016.07.001","article-title":"Actualisation des recommandations de prise en charge du m\u00e9lanome stade I \u00e0 III","volume":"143","author":"Guillot","year":"2016","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.08.018_bib0125","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/jdv.14064","article-title":"French updated recommendations in Stage I to III melanoma treatment and management","volume":"31","author":"Guillot","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.08.018_bib0130","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2019.08.018_bib0135","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2019.08.018_bib0140","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009\u00a0AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annder.2019.08.018_bib0145","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2019.08.018_bib0150","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3\u00a0trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.annder.2019.08.018_bib0155","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2019.08.018_bib0160","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2019.08.018_bib0165","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1468-3083.2011.04267.x","article-title":"Sentinel lymph node biopsy for melanoma is becoming a consensus: a national survey of French centres involved in melanoma care in 2008","volume":"26","author":"Lourari","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.08.018_bib0170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.2017.75.7724","article-title":"Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update","volume":"36","author":"Wong","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annder.2019.08.018_bib0175","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1245\/s10434-014-3758-7","article-title":"Observation after a positive sentinel lymph node biopsy in patients with melanoma","volume":"21","author":"Bamboat","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.annder.2019.08.018_bib0180","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1245\/ASO.2006.03.058","article-title":"Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study","volume":"13","author":"Wong","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.annder.2019.08.018_bib0185","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.annder.2019.08.018_bib0190","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1056\/NEJMe1704290","article-title":"The enigma of regional lymph nodes in melanoma","volume":"376","author":"Coit","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2019.08.018_bib0195","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMc1708918","article-title":"Melanoma Sentinel-Node Metastasis","volume":"377","author":"Bilimoria","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2019.08.018_bib0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMclde1712449","article-title":"Management of Sentinel-Node Metastasis in Melanoma","volume":"378","author":"Caulley","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2019.08.018_bib0205","first-page":"472","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.annder.2019.08.018_bib0210","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejca.2017.11.023","article-title":"Eighth American Joint Committee on Cancer (AJCC) melanoma classification: let us reconsider stage III","volume":"91","author":"Grob","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.annder.2019.08.018_bib0215","first-page":"CD008955","article-title":"Interferon alpha for the adjuvant treatment of cutaneous melanoma","volume":"6","author":"Mocellin","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.annder.2019.08.018_bib0220","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","article-title":"Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy","volume":"375","author":"Eggermont","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2019.08.018_bib0110","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S015196381930941X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S015196381930941X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:07:56Z","timestamp":1758971276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S015196381930941X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S015196381930941X"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2019.08.018","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M\u00e9lanome au stade ganglionnaire\u00a0: analyse du ganglion sentinelle, curage ganglionnaire, perspective des traitements adjuvants. Enqu\u00eate nationale fran\u00e7aise sur les pratiques actuelles et envisag\u00e9es","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2019.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}